MUMBAI, India, March 1 -- Intellectual Property India has published a patent application (202437009045 A) filed by Ucme Bioscience S. R. L., Siena, Italy, on Feb. 10, for 'neutralising anti-cd93 antibodies and their use in the diagnosis and treatment of cancer.'
Inventor(s) include Galvagni, Federico; Orlandini, Maurizio; and Tosi, Gian Marco.
The application for the patent was published on March 1, under issue no. 09/2024.
According to the abstract released by the Intellectual Property India: "The present invention concerns the field of angiogenesis-related disorders such as Age-related macular degeneration, diabetic retinopathies and tumor diseases, and in particular to compounds suitable for the treatment thereof. The invention relate...